Seek Returns logo

ASND vs. MDGL: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at ASND and MDGL, comparing key factors like performance, valuation metrics, dividends, and financial strength.

Company Overview

ASND’s market capitalization of 10.45 billion USD is substantially larger than MDGL’s 6.18 billion USD, indicating a significant difference in their market valuations.

ASND has a positive beta (0.36), indicating it generally moves with the broader market, whereas MDGL has a negative beta (-1.08), often moving inversely, which can offer diversification or hedging benefits.

ASND trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, MDGL is a standard domestic listing.

SymbolASNDMDGL
Company NameAscendis Pharma A/SMadrigal Pharmaceuticals, Inc.
CountryDKUS
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
CEOMr. Jan Moller MikkelsenMr. William J. Sibold
Price173.06 USD278.23 USD
Market Cap10.45 billion USD6.18 billion USD
Beta0.36-1.08
ExchangeNASDAQNASDAQ
IPO DateJanuary 28, 2015February 6, 2007
ADRYesNo

Performance Comparison

This chart compares the performance of ASND and MDGL over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

This section compares the market valuation of ASND and MDGL. Key takeaways regarding their valuation, when viewed within their industry context, are presented in the commentary that follows.

  • ASND’s Price-to-Earnings (P/E) ratio of -26.69 and MDGL’s P/E ratio of -15.70 both indicate negative earnings. For ASND, this signifies current unprofitability, raising questions about its operational efficiency or market conditions. MDGL’s negative P/E also reflects a lack of current earnings, a key concern for its financial health and investor appeal.
  • ASND’s Forward PEG ratio of -2.42 and MDGL’s Forward PEG ratio of -0.85 are both in the negative range. For ASND, a negative PEG ratio often stems from negative current earnings or forecasts of declining earnings, making its valuation difficult to assess relative to growth. Similarly, MDGL’s negative PEG suggests underlying issues with profitability or growth expectations, raising questions about its stock price compared to future prospects.
  • ASND’s Price-to-Book (P/B) ratio of -48.04 reflects a negative book value (meaning negative shareholder equity). This is a significant indicator of financial distress and raises substantial concerns about its solvency.
SymbolASNDMDGL
Price-to-Earnings Ratio (P/E, TTM)-26.69-15.70
Forward PEG Ratio (TTM)-2.42-0.85
Price-to-Sales Ratio (P/S, TTM)24.8819.46
Price-to-Book Ratio (P/B, TTM)-48.048.65
EV-to-EBITDA (TTM)-38.73-16.25
EV-to-Sales (TTM)25.7719.26

Dividend Comparison

Neither ASND nor MDGL currently pays a dividend; this often suggests they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.

SymbolASNDMDGL
Dividend Yield (TTM)0.00%0.00%

Financial Strength Metrics Comparison

This section evaluates the financial strength of ASND and MDGL. Noteworthy observations on their financial resilience, considered from an industry perspective, are detailed in the points that follow.

  • ASND’s Debt-to-Equity (D/E) ratio of -4.46 indicates negative shareholder equity. This is a significant red flag, suggesting its liabilities exceed its assets and posing a considerable threat to its long-term financial health.
  • ASND’s Interest Coverage Ratio (ICR) of -3.72 and MDGL’s ICR of -30.09 are both negative. For ASND, a negative ICR means its operating earnings are insufficient to cover its interest expenses, a critical indicator of financial distress. MDGL’s negative ICR likewise signals severe difficulty in servicing its debt and raises concerns about its ongoing financial stability.
SymbolASNDMDGL
Current Ratio (TTM)1.045.91
Quick Ratio (TTM)0.715.58
Debt-to-Equity Ratio (TTM)-4.460.17
Debt-to-Asset Ratio (TTM)0.800.12
Net Debt-to-EBITDA Ratio (TTM)-1.340.17
Interest Coverage Ratio (TTM)-3.72-30.09